US Patent Issued to Kissei Pharmaceutical on April 22 for "Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis" (Swiss Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,052, issued on April 22, was assigned to Kissei Pharmaceutical Co. Ltd. (Matsumoto, Japan).

"Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis" was invented by Jean-Pierre Gotteland (Geneva) and Ernest Loumaye (Cologny, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods for treating endometrial growth disorders in a patient, such as a human patient, and particularly pre-menopausal female human patients. Exemplary disorders that may be treated using the compounds and therapeutic regimens described herein include adenomyosis and rectovaginal endometr...